Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2010 Febbraio;76(2) > Minerva Anestesiologica 2010 Febbraio;76(2):115-9

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA ANESTESIOLOGICA

Rivista di Anestesia, Rianimazione, Terapia Antalgica e Terapia Intensiva


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036


eTOC

 

ORIGINAL ARTICLES  


Minerva Anestesiologica 2010 Febbraio;76(2):115-9

lingua: Inglese

The pharmacodynamic effects of rocuronium during general anesthesia in patients with type 2 diabetes mellitus

Alper I., Ulukaya S., Makay O., Balcioglu T.

Department of Anesthesiology and Reanimation, Ege University School of Medicine, Izmir, Turkey


FULL TEXT  


AIM. The aim of this prospective study was to investigate whether the neuromuscular response to rocuronium is affected by the presence of type 2 diabetes mellitus.
METHODS: Neuromuscular functions were measured after the administration of 0.6 mg/kg rocuronium with train-of-four stimulations in patients with type 2 diabetes mellitus (DM, N=14) and without diabetes mellitus (control, N=14) during isoflurane based general anesthesia. The onset time, clinical duration and recovery index of rocuronium were compared in the two groups.
RESULTS: The mean onset time (136 ± 40 vs 118 ± 20 s), clinical duration (51 ± 11 vs 48 ± 11 min) and recovery index (6.0 ± 2.5 vs 5.9 ± 1.4 min) of the neuromuscular block were not significantly different between the DM and control groups, respectively (p>0.05).
CONCLUSIONS: The present study has proven that the rocuronium-induced neuromuscular block was not affected in patients with type 2 diabetes mellitus during isoflurane based general anesthesia.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

i.alper@yahoo.com